United States· US:0597-7313_86fd1ab2-c0a5-4ab7-8ae7-da8b42c169ca
JASCAYD
A nerandomilast product containing nerandomilast, registered in United States by Boehringer Ingelheim Pharmaceuticals, Inc.. The same ATC class is registered in 9 of our 19 countries.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
Where it is registered
Nerandomilast is registered in 9 of 19 countries.
Countries holding a registration under ATC L04AA61 (nerandomilast), each read from that country’s own register.
- This record: United States, from FDA National Drug Code directory (United States)
- 5 of them publish a price we can compare per daily dose
Nerandomilast · ATC L04AA61
9 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Ireland
- Japan
- Netherlands
- Polandprice
- United Statesprice
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- NERANDOMILAST
- Manufacturer
- Boehringer Ingelheim Pharmaceuticals, Inc.
- Country
- United States (US)
- ATC code
- L04AA61
- ATC class
- Nerandomilast
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- August 30, 2026
Packs & prices · 2
- ndc1105977313211 BOTTLE, PLASTIC in 1 CARTON (0597-7313-21) / 60 TABLET, FILM COATED in 1 BOTTLE, PLASTIC
- ndc110597-7313-21
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Nerandomilast in 8 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaJASCAYDBoehringer Ingelheim International GmbH, Ingelheim am Rhein
- SpainJASCAYD 18 MG COMPRIMIDOS RECUBIERTOS CON PELICULABoehringer Ingelheim International Gmbh
- FinlandJascaydBoehringer Ingelheim International GmbH
- IrelandJascayd 18 mg film-coated tabletsBoehringer Ingelheim International GmbH
- NetherlandsJascayd 18 mg filmomhulde tablettenBoehringer Ingelheim International GmbH
- PolandJascaydBoehringer Ingelheim International GmbH
- SwedenJascayd 18 mg Filmdragerad tablettBoehringer Ingelheim International GmbH
- BelgiumJascayd 18 mgBoehringer Ingelheim International
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Jascayd
- Liechtenstein · Jascayd
- Norway · Jascayd
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/a66ad6d4-6c4e-4db1-a935-57c686972017 GET /v1/drugs/a66ad6d4-6c4e-4db1-a935-57c686972017?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "ORAL",
"source": "ndc",
"strength": "18",
"substance": "NERANDOMILAST",
"productndc": "0597-7313",
"dosage_form": "TABLET, FILM COATED",
"dea_schedule": null,
"strength_unit": "mg/1",
"application_number": "NDA218764",
"marketing_category": "NDA"
}See everything about nerandomilast.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.